Literature DB >> 18664856

Predicting the fate of acute ischemic lesions using perfusion computed tomography.

Hiroshi Hagiwara1, Hidenori Nakamura, Hironaka Igarashi, Yasuo Katayama.   

Abstract

OBJECTIVE: To investigate whether the prognosis of ischemic tissues in acute cerebral ischemia can be predicted using perfusion computed tomography-derived parameters and, if so, which are the most useful.
METHODS: Perfusion computed tomography was performed on 13 ischemic stroke patients within 6 hours of ischemic onset. The absolute and normalized values of regional cerebral blood flow (rCBF), regional cerebral blood volume, and regional mean transit time (rMTT) and their mirror regions were divided into those that infarcted or survived. Receiver operating characteristic analysis was subsequently conducted for these 3 parameters, and their relationship to the threshold and predictability of infarction were evaluated.
RESULTS: Acute ischemic lesions with less than 63% of normal rCBF or more than 220% of rMTT almost invariably led to infarction; moreover, the receiver operating characteristic analysis revealed that both rMTT and rCBF, and their normalized derivatives, were equally predictive of infarction.
CONCLUSION: Both rCBF and rMTT can be used to predict the ultimate pathological prognosis of cerebral ischemia. Perfusion computed tomography is a very useful early-stage tool for the assessment of these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18664856     DOI: 10.1097/RCT.0b013e31813fcff7

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  1 in total

1.  Regional cerebral perfusion and ischemic status after standard superficial temporal artery-middle cerebral artery (STA-MCA) bypass surgery in ischemic cerebrovascular disease.

Authors:  Jie Bai; Yuan-li Zhao; Rong Wang; Dong Zhang; Shuo Wang; Ji-zong Zhao; Jun Wu
Journal:  Childs Nerv Syst       Date:  2012-01-04       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.